Table 2 |
|||||||
|
Frequency distribution among different categories for the top eight genes. |
|||||||
|
Gene |
# of Samples |
Others |
Drug |
Genetic lesion detected |
Genetic lesion not detected |
Genetic lesion mentioned |
Gene only |
|
|
|||||||
|
ALK |
102 |
32 |
10 |
41 |
15 |
4 |
0 |
|
|
|||||||
|
BRAF |
130 |
0 |
32 |
63 |
13 |
21 |
1 |
|
|
|||||||
|
EGFR |
200 |
4 |
117 |
37 |
5 |
26 |
11 |
|
|
|||||||
|
KIT |
145 |
5 |
26 |
82 |
12 |
16 |
4 |
|
|
|||||||
|
KRAS |
200 |
2 |
0 |
65 |
95 |
38 |
0 |
|
|
|||||||
|
MET |
200 |
147 |
28 |
16 |
0 |
5 |
4 |
|
|
|||||||
|
PTEN |
69 |
4 |
2 |
41 |
1 |
19 |
2 |
|
|
|||||||
|
WT1 |
97 |
0 |
53 |
32 |
0 |
9 |
3 |
|
|
|||||||
|
Total |
1,143 |
194 |
268 |
377 |
141 |
138 |
25 |
|
|
|||||||
|
Wu et al. BMC Genomics 2012 13(Suppl 8):S21 doi:10.1186/1471-2164-13-S8-S21 |
|||||||
